Do analysts recommend MBOT or PETV?

Microbot Medical presently has a consensus price target of $6.38, indicating a potential upside of 342.71%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Microbot Medical is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is MBOT or PETV more profitable?

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.87% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Microbot Medical N/A -21.87% -20.76% PetVivo -902.82% -4,813.07% -281.78%

Does the media prefer MBOT or PETV?

In the previous week, Microbot Medical and Microbot Medical both had 1 articles in the media. Microbot Medical's average media sentiment score of 1.53 beat PetVivo's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate PETV or HYPR?

Hyperfine has a consensus price target of $2.03, suggesting a potential upside of 150.01%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Hyperfine 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is PETV or HYPR more profitable?

Hyperfine has a net margin of -210.75% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -97.88% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% Hyperfine -210.75% -97.88% -61.81%

Do analysts prefer PETV or ECOR?

electroCore has a consensus price target of $18.00, suggesting a potential upside of 95.44%. Given electroCore's stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is PETV or ECOR more profitable?

electroCore has a net margin of -39.96% compared to PetVivo's net margin of -902.82%. electroCore's return on equity of -1,956.38% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets PetVivo -902.82% -4,813.07% -281.78% electroCore -39.96% -1,956.38% -81.35%

Do analysts recommend CVRX or PETV?

CVRx currently has a consensus target price of $5.30, suggesting a potential upside of 73.77%. Given CVRx's stronger consensus rating and higher possible upside, research analysts clearly believe CVRx is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, CVRX or PETV?

PetVivo has lower revenue, but higher earnings than CVRx. PetVivo is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.43 -$53.31M -$1.98 N/A PetVivo $1.05M 24.67 -$10.95M -$0.34 N/A

Is CVRX or PETV more profitable?

CVRx has a net margin of -84.93% compared to PetVivo's net margin of -902.82%. CVRx's return on equity of -152.35% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% PetVivo -902.82% -4,813.07% -281.78%

Does the media prefer CVRX or PETV?

In the previous week, CVRx had 4 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for CVRx and 1 mentions for PetVivo. CVRx's average media sentiment score of 0.63 beat PetVivo's score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend OM or PETV?

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 178.55%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts clearly believe Outset Medical is more favorable than PetVivo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 PetVivo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is OM or PETV more profitable?

Outset Medical has a net margin of -63.06% compared to PetVivo's net margin of -902.82%. Outset Medical's return on equity of -61.67% beat PetVivo's return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.06% -61.67% -28.25% PetVivo -902.82% -4,813.07% -281.78%

Does the media prefer OM or PETV?

In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Outset Medical's average media sentiment score of 1.34 beat PetVivo's score of 0.00 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PetVivo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

PetVivo (PETV) Competitors

$0.68 0.00 (0.00%)

As of 09/4/2026 02:27 PM Eastern

Compare

PETV vs. MBOT, HYPR, ECOR, CVRX, and OM

Should you buy PetVivo stock or one of its competitors? PetVivo's main competitors and comparable companies include Microbot Medical (MBOT), Hyperfine (HYPR), electroCore (ECOR), CVRx (CVRX), and Outset Medical (OM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PetVivo compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Microbot Medical presently has a consensus price target of $6.38, indicating a potential upside of 342.71%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Microbot Medical is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

PetVivo has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A
PetVivo	$1.05M	24.67	-$10.95M	-$0.34	N/A

In the previous week, Microbot Medical and Microbot Medical both had 1 articles in the media. Microbot Medical's average media sentiment score of 1.53 beat PetVivo's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market.

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.87% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.87%	-20.76%
PetVivo	-902.82%	-4,813.07%	-281.78%

Summary

Microbot Medical beats PetVivo on 8 of the 14 factors compared between the two stocks.

How does PetVivo compare to Hyperfine?

PetVivo (NASDAQ:PETV) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Hyperfine has a net margin of -210.75% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -97.88% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
Hyperfine	-210.75%	-97.88%	-61.81%

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.67	-$10.95M	-$0.34	N/A
Hyperfine	$11.40M	7.57	-$35.57M	-$0.38	N/A

PetVivo has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market.

In the previous week, PetVivo had 1 more articles in the media than Hyperfine. MarketBeat recorded 1 mentions for PetVivo and 0 mentions for Hyperfine. PetVivo's average media sentiment score of 0.00 equaled Hyperfine'saverage media sentiment score.

Company	Overall Sentiment
PetVivo	Neutral
Hyperfine	Neutral

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 26.3% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hyperfine has a consensus price target of $2.03, suggesting a potential upside of 150.01%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hyperfine	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Hyperfine beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does PetVivo compare to electroCore?

PetVivo (NASDAQ:PETV) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

electroCore has a consensus price target of $18.00, suggesting a potential upside of 95.44%. Given electroCore's stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, PetVivo had 1 more articles in the media than electroCore. MarketBeat recorded 1 mentions for PetVivo and 0 mentions for electroCore. PetVivo's average media sentiment score of 0.00 equaled electroCore'saverage media sentiment score.

Company	Overall Sentiment
PetVivo	Neutral
electroCore	Neutral

24.5% of PetVivo shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 7.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

PetVivo has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market. Comparatively, electroCore has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.

electroCore has a net margin of -39.96% compared to PetVivo's net margin of -902.82%. electroCore's return on equity of -1,956.38% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
electroCore	-39.96%	-1,956.38%	-81.35%

PetVivo has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	24.67	-$10.95M	-$0.34	N/A
electroCore	$32.03M	2.59	-$13.97M	-$1.66	N/A

Summary

electroCore beats PetVivo on 8 of the 15 factors compared between the two stocks.

How does PetVivo compare to CVRx?

CVRx (NASDAQ:CVRX) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.

CVRx has a net margin of -84.93% compared to PetVivo's net margin of -902.82%. CVRx's return on equity of -152.35% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
PetVivo	-902.82%	-4,813.07%	-281.78%

75.3% of CVRx shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 16.6% of CVRx shares are held by company insiders. Comparatively, 10.8% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

PetVivo has lower revenue, but higher earnings than CVRx. PetVivo is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.43	-$53.31M	-$1.98	N/A
PetVivo	$1.05M	24.67	-$10.95M	-$0.34	N/A

CVRx has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, PetVivo has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market.

CVRx currently has a consensus target price of $5.30, suggesting a potential upside of 73.77%. Given CVRx's stronger consensus rating and higher possible upside, research analysts clearly believe CVRx is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, CVRx had 4 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for CVRx and 1 mentions for PetVivo. CVRx's average media sentiment score of 0.63 beat PetVivo's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CVRx beats PetVivo on 11 of the 16 factors compared between the two stocks.

How does PetVivo compare to Outset Medical?

Outset Medical (NASDAQ:OM) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

24.5% of PetVivo shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Outset Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.36, suggesting that its stock price is 36% more volatile than the broader market.

Outset Medical has a net margin of -63.06% compared to PetVivo's net margin of -902.82%. Outset Medical's return on equity of -61.67% beat PetVivo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
PetVivo	-902.82%	-4,813.07%	-281.78%

In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Outset Medical's average media sentiment score of 1.34 beat PetVivo's score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PetVivo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 178.55%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts clearly believe Outset Medical is more favorable than PetVivo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

PetVivo has lower revenue, but higher earnings than Outset Medical. PetVivo is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.56	-$81.65M	-$4.09	N/A
PetVivo	$1.05M	24.67	-$10.95M	-$0.34	N/A

Summary

Outset Medical beats PetVivo on 10 of the 15 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PETV vs. The Competition

Export

Metric	PetVivo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$25.81M	$5.66B	$7.21B	$12.89B
Dividend Yield	N/A	1.76%	2.54%	9.13%
P/E Ratio	-1.51	25.99	273.84	25.45
Price / Sales	24.67	72.95	625.55	100.83
Price / Cash	N/A	33.42	28.92	35.62
Price / Book	-22.67	6.10	11.01	6.39
Net Income	-$10.95M	$150.94M	$3.49B	$358.69M
7 Day Performance	N/A	-1.07%	1.63%	0.22%
1 Month Performance	4.62%	1.02%	4.42%	-0.10%
1 Year Performance	-15.00%	9.91%	24.21%	14.04%

PetVivo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PETV PetVivo	N/A	$0.68 flat	N/A	-15.0%	$25.81M	$1.05M	N/A	20	Gap Down
MBOT Microbot Medical	2.6369 of 5 stars	$1.48 -1.3%	$6.38 +330.7%	-60.7%	$100.75M	N/A	N/A	20	Positive News Analyst Downgrade Gap Up
HYPR Hyperfine	1.848 of 5 stars	$0.83 -1.4%	$2.03 +144.0%	-30.5%	$89.65M	$11.40M	N/A	190
ECOR electroCore	2.6506 of 5 stars	$9.63 -0.8%	$18.00 +86.9%	+88.3%	$87.54M	$32.03M	N/A	50
CVRX CVRx	3.6402 of 5 stars	$2.95 -3.0%	$5.30 +79.7%	-61.0%	$80.99M	$56.65M	N/A	160

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PETV) was last updated on 9/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PetVivo (PETV) Competitors

PETV vs. MBOT, HYPR, ECOR, CVRX, and OM

How does PetVivo compare to Microbot Medical?

Summary

How does PetVivo compare to Hyperfine?

Summary

How does PetVivo compare to electroCore?

Summary

How does PetVivo compare to CVRx?

Summary

How does PetVivo compare to Outset Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PetVivo (PETV) Competitors

PETV vs. MBOT, HYPR, ECOR, CVRX, and OM

How does PetVivo compare to Microbot Medical?

Do analysts recommend MBOT or PETV?

Which has better valuation & earnings, MBOT or PETV?

Does the media prefer MBOT or PETV?

Which has more volatility & risk, MBOT or PETV?

Do insiders and institutionals believe in MBOT or PETV?

Is MBOT or PETV more profitable?

Summary

How does PetVivo compare to Hyperfine?

Is PETV or HYPR more profitable?

Which has higher valuation & earnings, PETV or HYPR?

Which has more volatility and risk, PETV or HYPR?

Does the media favor PETV or HYPR?

Do institutionals & insiders hold more shares of PETV or HYPR?

Do analysts rate PETV or HYPR?

Summary

How does PetVivo compare to electroCore?

Do analysts prefer PETV or ECOR?

Does the media favor PETV or ECOR?

Do institutionals & insiders hold more shares of PETV or ECOR?

Which has more risk & volatility, PETV or ECOR?

Is PETV or ECOR more profitable?

Which has preferable valuation & earnings, PETV or ECOR?

Summary

How does PetVivo compare to CVRx?

Is CVRX or PETV more profitable?

Do insiders and institutionals hold more shares of CVRX or PETV?

Which has higher valuation & earnings, CVRX or PETV?

Which has more volatility & risk, CVRX or PETV?

Do analysts recommend CVRX or PETV?

Does the media prefer CVRX or PETV?

Summary

How does PetVivo compare to Outset Medical?

Do institutionals and insiders have more ownership in OM or PETV?

Which has more volatility and risk, OM or PETV?

Is OM or PETV more profitable?

Does the media prefer OM or PETV?

Do analysts recommend OM or PETV?

Which has preferable valuation & earnings, OM or PETV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PETV vs. The Competition

PetVivo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools